Back to funds

BIOS Capital Management, LP

hedge fundUpdated 9 days ago

Managed by Bios Capital Management, Lp • Latest filing Q3 2026

Portfolio value
$34.2B
Q3 2026
Filings
4
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings

Portfolio value history

13F-disclosed portfolio value over 4 quarters

Show data table
PeriodPortfolio value
Q4 2025$82.6M
Q1 2026$52.9M
Q2 2026$41.7M
Q3 2026$34.2B

Top holdings

9 positions as of Q3 2026

View filing
I

OPUS GENETICS INC

Value
$17.8B
Shares
3.68M
% Port
52.17%
?
2.N/A

ACTUATE THERAPEUTICS INC

Value
$6.7B
Shares
8.59M
% Port
19.62%
C

COGNITION THERAPEUTICS INC

Value
$5.3B
Shares
5.50M
% Port
15.45%
?
4.N/A

REIN THERAPEUTICS INC

Value
$1.4B
Shares
1.76M
% Port
4.14%
?
5.N/A

ACTUATE THERAPEUTICS INC

Value
$1.1B
Shares
1.46M
% Port
3.32%
?
6.N/A

REIN THERAPEUTICS INC

Value
$984.1M
Shares
1.22M
% Port
2.88%
C

COGNITION THERAPEUTICS INC

Value
$480.1M
Shares
500.1K
% Port
1.41%
L

LANTERN PHARMA INC

Value
$238.3M
Shares
235.9K
% Port
0.70%
?
9.N/A

IN8BIO INC

Value
$107.7M
Shares
81.0K
% Port
0.32%

Explore